Benzalkonium chloride and nasal mucociliary clearance: A randomized, placebo-controlled, crossover, double-blind trial

American Journal of Rhinology

Volumn 20, Issue 3, 2006, Pages 243-247

  Rizzo, José Ângelo ^a   Medeiros, Décio ^a   Silva, Almerinda Rego ^a   Sarinho, Emanuel ^a,b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; NOSE SPRAY; PLACEBO; SALSEP; SODIUM CHLORIDE; SORINE INFANTIL; STRONTIUM; TECHNETIUM 99M;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG USE; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MUCOCILIARY CLEARANCE; NORMAL HUMAN; NOSE INJURY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; STATISTICAL SIGNIFICANCE; VOLUNTEER;

ADOLESCENT; ADULT; BENZALKONIUM COMPOUNDS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOCILIARY CLEARANCE; PRESERVATIVES, PHARMACEUTICAL;

EID: 33746177513     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2006.20.2867     Document Type: Article

References (20)

1. Grosselin RE, Smith RP, Hodge H (Eds.) Benzalkonium chloride. In Clinical Toxicology of Commercial Products, 5th ed. Baltimore: Williams & Wilkins, 63-66, 1984.
2. Bernstein IL. Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport. J Allergy Clin Immunol 106:595-596, 2000.
3. Graf P. Benzalconium chloride as a preservative in nasal solutions: Re-examining the data. Respir Med 95:728-733, 2001.
4. Moher D, Schulz KF, and Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomises trials. Lancet 357: 1191-1194, 2001.
5. Friedman LM, Furberg CD, and DeMets DL (Eds.). Sample size. In Clinical Trials, 3rd ed. St. Louis, MO: Mosby-Year Book, Inc., 94-129, 1996.
6. Doyle WJ, Skoner DP, Hayden F, et al. Nasal and otologic effects of experimental influenza A virus infection. Ann Otol Rhinol Laryngol 103:59-69, 1994.
7. Pocock SJ (Ed). Crossover trials. In Clinical Trials. A Practical Approach. Chichester, England: Wiley & Sons, Ltd., 110-122, 1983.
8. Lale AM, Mason JDT, and Jones NS. Mucociliary transport and its assessment: A review. Clin Otolaryngol 23:388-396, 1998.
9. Naclerio RM, Baroody FM, Bidani N, et al. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg 128:220-227, 2003.
10. Marple B, Roland P, and Benninger M. Safety Review of benzalkonium chloride used as preservative in intranasal solutions: An overview of conflicting data and opinions. Otolaryngol Head Neck Surg 130:131-141, 2004.
11. Graf P, Hallen H, and Juto JE. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers. Clin Exp Allergy 25:395-400, 1995.
12. Graf P, and Hallen H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope 106:605-609, 1996.
13. Lebe E, Baka M, Yavasoglu A, et al. Effects of preservatives in nasal formulations on the mucosal integrity: An electron microscopic study. Pharmacology 72:113-120, 2004.
14. Riechelmann H, Deutschle T, Stuhlmiller A, et al. Nasal toxicity of benzalkonium chloride. Am J Rhinol 18:291-299, 2004.
15. Hofmann T, Gugatschga M, Koidl B, et al. Influence of preservatives and topical steroids on ciliary beat frequency in vitro. Arch Otolaryngol Head Neck Surg 130:440-445, 2004.
16. Graf P, Enerdal J, and Hallen H. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch Otolaryngol Head Neck Surg 125:1128-1132, 1999.
17. Graf P. Adverse effects of benzalkonium chloride on the nasal mucosa: Allergic rhinitis and rhinitis medicamentosa. Clin Ther 21:1749-1755, 1999.
18. Boston M, Dobratz EJ, Buescher ES, et al. Effects of nasal saline spray on human neutrophils. Arch Otolaryngol Head Neck Surg 129:660-664, 2003.
19. Weiderpass E, Beria JU, Barros FC, et al. Epidemiology of drug use during the first three months of life in a urban area of southern Brazil. Rev Saude Publica 32:335-344, 1998.
20. Verse T, Sikora C, Rudolph P, et al. The tolerability of nasal drugs with special regard to preservatives and physicochemical parameter. Laryngorhinootologie 82:782-789, 2003.